Literature DB >> 2922702

Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombin.

Y S Kim1, R J Linhardt.   

Abstract

Heparins from different species and tissues show similar levels of ATIII and HCII mediated anti-IIa activities. On fractionation, chains containing predominantly ATIII or HCII activities could not be separated. Oligosaccharide mapping demonstrates that the concentration of an oligosaccharide comprising a portion of heparin's ATIII binding site in a particular heparin fraction correlates with ATIII mediated anti-IIa activity, but does not correlate with HCII mediated anti-IIa activity. These results suggest that ATIII and HCII do not share a common binding site. Partial enzymatic depolymerization of heparin resulted in large oligosaccharides which could be purified and partially characterized. Although oligosaccharides of degree of polymerization (dp) 18 and 20 showed significant ATIII and HCII mediated anti-IIa activities no separation of these activities resulted. These data suggest however that a minimum chain length of dp18 was required for HCII mediated anti-IIa activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2922702     DOI: 10.1016/0049-3848(89)90115-1

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

Review 1.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

2.  Structural and activity variability of fractions with different charge density and chain length from pharmaceutical heparins.

Authors:  Yanlei Yu; Makoto Hirakane; Daisuke Mori; Lei Lin; Fuming Zhang; Hong Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2017-05-29       Impact factor: 2.916

Review 3.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

4.  Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates.

Authors:  Richard Karlsson; Pradeep Chopra; Apoorva Joshi; Zhang Yang; Sergey Y Vakhrushev; Thomas Mandel Clausen; Chelsea D Painter; Gergo P Szekeres; Yen-Hsi Chen; Daniel R Sandoval; Lars Hansen; Jeffrey D Esko; Kevin Pagel; Douglas P Dyer; Jeremy E Turnbull; Henrik Clausen; Geert-Jan Boons; Rebecca L Miller
Journal:  Sci Adv       Date:  2021-12-22       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.